Dual VEGF-Targeting Strategy Via AAV2-Delivered sFLT-1 and shVEGF for Retinal Neovascularization Therapy. Chen C, Yang X, Jiang Z, Wang M, et al. Invest Ophthalmol Vis Sci 2025;66:37.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen C, Yang X, Jiang Z, Wang M, et al. Dual VEGF-Targeting Strategy Via AAV2-Delivered sFLT-1 and shVEGF for Retinal Neovascularization Therapy. Invest Ophthalmol Vis Sci 2025;66:37.
PMID: 40810574